He aha te tikanga o te "Maama"?
Karekau te kararehe e kawe i te huringa. E kore e whakawhanake i te mate a e kore e tukuna atu.
Achromatopsia Type 2 (ACHM2) in Labrador Retrievers is a genetic condition causing complete color blindness and vision impairment. This DNA test identifies carriers and affected dogs, helping breeders make informed decisions to reduce the risk of passing ACHM2 to puppies. Early detection through genetic testing ensures better management and care for affected Labradors. By using the ACHM2 DNA test, breeders promote healthier bloodlines and improve the overall quality of life for their dogs. This test is essential for responsible Labrador Retriever breeding programs focused on eye health. Protect your Labrador’s vision with accurate ACHM2 genetic screening today. Stay informed and support canine genetic health with reliable DNA testing services.
Achromatopsia Type 2 (ACHM2) in Labrador Retrievers is a genetic condition causing complete color blindness and light sensitivity. This inherited disorder affects the cone cells in the retina, leading to vision problems from an early age. A DNA test can identify carriers and affected dogs, helping breeders make informed decisions. Early detection through genetic testing is crucial for managing the health and well-being of affected Labradors. Responsible breeding can reduce the incidence of ACHM2 in future generations.
Kua whakauruhia tenei whakamatautau DNA mai i ta maatau kete Basic — he waahanga ano hoki o nga kete Basic, Standard, Advanced, Complete.
Tirohia nga Puka Whakamatau DNA →Achromatopsia Type 2 (ACHM2) is a genetic eye disorder that affects the vision of Labrador Retrievers. This condition results from mutations in the CNGB3 gene, which plays a crucial role in the function of photoreceptor cells in the retina. Affected dogs exhibit a range of visual impairments, primarily characterized by a lack of color vision and sensitivity to bright light.
Dogs with Achromatopsia Type 2 typically demonstrate several noticeable symptoms. These may include photophobia (aversion to bright light), nystagmus (involuntary eye movement), and reduced visual acuity. Owners may observe their pets having difficulty navigating in brightly lit environments or showing signs of discomfort in sunlight. The condition often leads to a significant reduction in the quality of life, as affected dogs may struggle with everyday activities.
The underlying cause of Achromatopsia Type 2 is linked to genetic mutations in the CNGB3 gene, which is essential for the normal functioning of cone photoreceptors in the retina. These photoreceptors are responsible for color vision and visual clarity. When the CNGB3 gene is mutated, it disrupts the normal signaling pathways, leading to the characteristic symptoms of achromatopsia. The condition follows an autosomal recessive inheritance pattern, meaning that both parents must carry the mutated gene for the offspring to be affected.
Diagnosis of Achromatopsia Type 2 is typically confirmed through genetic testing. A DNA test can identify the presence of mutations in the CNGB3 gene, providing a definitive diagnosis. Early identification of the condition is crucial for managing the visual challenges faced by affected Labrador Retrievers. Regular veterinary check-ups and consultations with a veterinary ophthalmologist can help monitor the progression of the disease and address any complications that may arise.
While there is no cure for Achromatopsia Type 2, management strategies can help improve the quality of life for affected Labrador Retrievers. Owners are encouraged to create a safe and accommodating environment, minimizing exposure to bright lights and ensuring that their pets have a clear understanding of their surroundings. Additionally, training and behavioral modifications can assist these dogs in adapting to their visual limitations, allowing them to navigate their environments more confidently.
Achromatopsia Type 2 is a significant genetic condition that affects the vision of Labrador Retrievers, resulting in challenges related to color perception and light sensitivity. Understanding the genetic basis and symptoms of this condition is vital for dog owners and breeders alike. With appropriate management and care, affected dogs can lead fulfilling lives despite their visual impairments.
Karekau te kararehe e kawe i te huringa. E kore e whakawhanake i te mate a e kore e tukuna atu.
Kao. He hauora te kararehe engari ka taea e ia te tuku i te huringa ki tona uri.
E rua nga kape whakarereke. Ko nga tohu haumanu kei te tumanakohia te mate. Kaua e whakatipuria.
Ko etahi o nga mate he hononga-a-ira, no reira ka rereke o raatau korero i runga i te ira kararehe.
This DNA test detects the mutation associated with Achromatopsia Type 2 In Labrador Retriever (ACHM2-LR) in order to identify clear, carrier, or at-risk animals.
Ko te whakamatautau DNA ka awhina i nga kaiwhakawhanake ki te whakamahere i nga hononga haumaru ake me te whakaiti i te tupono ki te tuku i te huringa ki nga uri.
Ko te tikanga tuku iho mo tenei whakamatautau ko Autosomal Recessive.
This test analyses the mutation CNGA3 c.1931_1933del.
Ehara i te mea. Ko te whakamaoritanga ka whakawhirinaki ki te tauira tuku iho me te momo momo ira ka puta.
Tanaka Naoto, Dutrow Emily V, Miyadera Keiko, Delemotte Lucie, MacDermaid Christopher M, Reinstein Shelby L, Crumley William R, Dixon Christopher J, Casal Margret L, Klein Michael L, Aguirre Gustavo D, Tanaka Jacqueline C, Guziewicz Karina E. Canine CNGA3 Gene Mutations Provide Novel Insights into Human Achromatopsia-Associated Channelopathies and Treatment. PLoS One. 2015 Sep 25;10(9):e0138943. doi: 10.1371/journal.pone.0138943. eCollection 2015.
To tūmataitinga, to whiringa
Ka whakamahi matou i nga pihikete whakahirahira hei whakahaere i te paetukutuku. Ko nga pihikete whiriwhiri (penei i nga kaiwhakarato ihirangi kua whakauruhia) kua monoa ma te taunoa ka whakahohea mena ka whakaae koe. Ka taea e koe te huri i to whiringa i nga wa katoa ma te whakamahi i te paatene "Pihikete".
E hiahiatia ana mo nga ahuatanga matua me te haumarutanga. Whakahohea i nga wa katoa.
Ka whakapai ake i nga ahuatanga penei i te penapena manakohanga, i nga taapiri kore-panui ranei.
Ka awhina tatou ki te mohio ki te whakamahinga o te waahi. Kua monoa e te taunoa.
Panuitanga / aroturuki puta noa i nga waahi (etahi riipene whakaata / mapi kua whakauruhia). Kua monoa e te taunoa.